{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T16:31:08Z","timestamp":1785429068223,"version":"3.56.0"},"reference-count":88,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82560547"],"award-info":[{"award-number":["82560547"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"award":["82560547"],"award-info":[{"award-number":["82560547"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"publisher"}]},{"name":"General Project of the Yunnan Province Science and Technology Department","award":["202301AT070478"],"award-info":[{"award-number":["202301AT070478"]}]},{"name":"General Project of the Yunnan Province Science and Technology Department","award":["202401AT070369"],"award-info":[{"award-number":["202401AT070369"]}]},{"award":["202301AT070478"],"award-info":[{"award-number":["202301AT070478"]}],"id":[{"id":"https:\/\/ror.org\/03whqdf70","id-type":"ROR","asserted-by":"publisher"}]},{"award":["202401AT070369"],"award-info":[{"award-number":["202401AT070369"]}],"id":[{"id":"https:\/\/ror.org\/03whqdf70","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Influenza viruses, due to their simple genomic structure and potent immunostimulatory capacity, have been extensively explored for applications in cancer immunotherapy and viral vector vaccine development. However, wild-type influenza viruses possess inherent risks of lethal pathogenicity and transmissibility, which limit their direct application. Special cold-adapted influenza strains have been widely used in live attenuated vaccines, which rely on specific amino acid mutations. With the advancement in synthetic biology and reverse genetics technologies, a variety of next-generation attenuated influenza virus have been developed, including genome-recoded viruses, miRNA-targeted viruses, viruses containing premature termination codons, and proteolysis-targeting recombinantviruses. This study systematically summarized the synthetic biology-based strategies for generating a next-generation method for the attenuated influenza virus, critically discussed the advantages and limitations of each strategy, and further analyzed their applications and challenges in cancer therapy and viral vector vaccine development. By synthesizing current research progress, this review aimed to provide a theoretical basis for constructing safer, more stable, and more controllable influenza virus engineering platforms, and to offer new insights for the design of attenuated influenza virus suitable for tumor therapy and novel vaccine delivery.<\/jats:p>","DOI":"10.3390\/v18070715","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T05:58:04Z","timestamp":1782799084000},"page":"715","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Synthetic Biology Strategies for the Development of Live Attenuated Influenza Viruses: Recent Advances and Applications"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-0721-373X","authenticated-orcid":false,"given":"Kai","family":"Yang","sequence":"first","affiliation":[{"name":"School of Basic Medical Sciences, Kunming University of Science and Technology, Kunming 650500, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangtao","family":"Yang","sequence":"additional","affiliation":[{"name":"School of Basic Medical Sciences, Kunming University of Science and Technology, Kunming 650500, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunxin","family":"Xia","sequence":"additional","affiliation":[{"name":"School of Basic Medical Sciences, Kunming University of Science and Technology, Kunming 650500, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7682-6094","authenticated-orcid":false,"given":"Xia","family":"Ou","sequence":"additional","affiliation":[{"name":"School of Basic Medical Sciences, Kunming University of Science and Technology, Kunming 650500, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1093\/infdis\/jiy703","article-title":"How Live Attenuated Vaccines Can Inform the Development of Broadly Cross-Protective Influenza Vaccines","volume":"219","author":"Rudraraju","year":"2019","journal-title":"J. Infect. Dis."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/(SICI)1099-1654(199910\/12)9:4<237::AID-RMV252>3.0.CO;2-G","article-title":"The development of live attenuated cold-adapted influenza virus vaccine for humans","volume":"9","author":"Maassab","year":"1999","journal-title":"Rev. Med. Virol."},{"key":"ref_3","first-page":"181","article-title":"Live attenuated influenza vaccine","volume":"386","author":"Jin","year":"2015","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref_4","first-page":"109","article-title":"Live attenuated vaccines for pandemic influenza","volume":"333","author":"Chen","year":"2009","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"6280","DOI":"10.1016\/j.vaccine.2020.07.043","article-title":"Immunogenicity and efficacy comparison of MDCK cell-based and egg-based live attenuated influenza vaccines of H5 and H7 subtypes in ferrets","volume":"38","author":"Yeolekar","year":"2020","journal-title":"Vaccine"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e1423171","DOI":"10.1080\/2162402X.2017.1423171","article-title":"Oncolytic influenza virus infection restores immunocompetence of lung tumor-associated alveolar macrophages","volume":"7","author":"Masemann","year":"2018","journal-title":"Oncoimmunology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1021\/acsnano.4c00654","article-title":"Tumor Vaccine Exploiting Membranes with Influenza Virus-Induced Immunogenic Cell Death to Decorate Polylactic Coglycolic Acid Nanoparticles","volume":"19","author":"Yang","year":"2025","journal-title":"ACS Nano"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e29308","DOI":"10.1002\/jmv.29308","article-title":"Cold-adapted influenza-vectored RSV vaccine protects BALB\/c mice and cotton rats from RSV challenge","volume":"96","author":"Xu","year":"2024","journal-title":"J. Med. Virol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/s41541-024-01033-5","article-title":"Intranasal influenza-vectored vaccine expressing pneumococcal surface protein A protects against Influenza and Streptococcus pneumoniae infections","volume":"9","author":"Cardoso","year":"2024","journal-title":"npj Vaccines"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e01794-19","DOI":"10.1128\/mBio.01794-19","article-title":"Influenza Virus Polymerase Mutation Stabilizes a Foreign Gene Inserted into the Virus Genome by Enhancing the Transcription\/Replication Efficiency of the Modified Segment","volume":"10","author":"Furusawa","year":"2019","journal-title":"mBio"},{"key":"ref_11","first-page":"554","article-title":"Identification of sequence changes in the cold-adapted, live attenuated influenza vaccine strain, A\/Ann Arbor\/6\/60 (H2N2)","volume":"167","author":"Cox","year":"1988","journal-title":"Virology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1128\/jvi.62.2.488-495.1988","article-title":"Four viral genes independently contribute to attenuation of live influenza A\/Ann Arbor\/6\/60 (H2N2) cold-adapted reassortant virus vaccines","volume":"62","author":"Snyder","year":"1988","journal-title":"J. Virol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Qian, W., Wei, X., Guo, K., Li, Y., Lin, X., Zou, Z., Zhou, H., and Jin, M. (2017). The C-Terminal Effector Domain of Non-Structural Protein 1 of Influenza A Virus Blocks IFN-\u03b2 Production by Targeting TNF Receptor-Associated Factor 3. Front. Immunol., 8.","DOI":"10.3389\/fimmu.2017.00779"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/S0021-9258(17)49923-6","article-title":"The influenza NS1 protein modulates RIG-I activation via a strain-specific direct interaction with the second CARD of RIG-I","volume":"295","author":"Jureka","year":"2020","journal-title":"J. Biol. Chem."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1126\/science.1222213","article-title":"An overlapping protein-coding region in influenza A virus segment 3 modulates the host response","volume":"337","author":"Jagger","year":"2012","journal-title":"Science"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e0190123","DOI":"10.1128\/jvi.01901-23","article-title":"Influenza A virus NS1 effector domain is required for PA-X-mediated host shutoff in infected cells","volume":"98","author":"Bougon","year":"2024","journal-title":"J. Virol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"8899","DOI":"10.1128\/JVI.75.19.8899-8908.2001","article-title":"Hyperattenuated recombinant influenza A virus nonstructural-protein-encoding vectors induce human immunodeficiency virus type 1 Nef-specific systemic and mucosal immune responses in mice","volume":"75","author":"Ferko","year":"2001","journal-title":"J. Virol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"4335836","DOI":"10.1155\/2024\/4335836","article-title":"Development of Live Vaccine Candidates for Canine Influenza H3N2 Using Naturally Truncated NS1 Gene","volume":"2024","author":"Hwang","year":"2024","journal-title":"Transbound. Emerg. Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1016\/j.vaccine.2022.03.051","article-title":"Efficacy of the NS1-truncated live attenuated influenza virus vaccine for swine against infection with viruses of major North American and European H3N2 lineages","volume":"40","author":"Vandoorn","year":"2022","journal-title":"Vaccine"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"156138","DOI":"10.1016\/j.cyto.2023.156138","article-title":"Hypoxia alters the immune response in mouse peritoneal macrophages infected with influenza a virus with truncated NS1 protein","volume":"164","year":"2023","journal-title":"Cytokine"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1099\/jgv.0.000232","article-title":"PA-X is a virulence factor in avian H9N2 influenza virus","volume":"96","author":"Gao","year":"2015","journal-title":"J. Gen. Virol."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Avanthay, R., Garcia-Nicolas, O., Zimmer, G., and Summerfield, A. (2023). NS1 and PA-X of H1N1\/09 influenza virus act in a concerted manner to manipulate the innate immune response of porcine respiratory epithelial cells. Front. Cell. Infect. Microbiol., 13.","DOI":"10.3389\/fcimb.2023.1222805"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1016\/j.vaccine.2023.01.018","article-title":"Development of in ovo-compatible NS1-truncated live attenuated influenza vaccines by modulation of hemagglutinin cleavage and polymerase acidic X frameshifting sites","volume":"41","author":"Ghorbani","year":"2023","journal-title":"Vaccine"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2445238","DOI":"10.1080\/21505594.2024.2445238","article-title":"The PA-X host shutoff site 100 V exerts a contrary effect on viral fitness of the highly pathogenic H7N9 influenza A virus in mice and chickens","volume":"16","author":"Chen","year":"2025","journal-title":"Virulence"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"4126","DOI":"10.1128\/JVI.02132-14","article-title":"PA-X decreases the pathogenicity of highly pathogenic H5N1 influenza A virus in avian species by inhibiting virus replication and host response","volume":"89","author":"Hu","year":"2015","journal-title":"J. Virol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.gene.2008.12.016","article-title":"Codon-pair usage and genome evolution","volume":"433","author":"Wang","year":"2009","journal-title":"Gene"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"110626","DOI":"10.1016\/j.virol.2025.110626","article-title":"Effects of synonymous codons with optimization\/deoptimization in nucleoprotein (NP) gene of influenza A virus on interaction between NP and tripartite motif protein 25 (TRIM25)","volume":"610","author":"Hu","year":"2025","journal-title":"Virology"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.meegid.2018.08.028","article-title":"Codon usage characteristics of PB2 gene in influenza A H7N9 virus from different host species","volume":"65","author":"Gun","year":"2018","journal-title":"Infect. Genet. Evol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s10709-022-00155-9","article-title":"Human genes with codon usage bias similar to that of the nonstructural protein 1 gene of influenza A viruses are conjointly involved in the infectious pathogenesis of influenza A viruses","volume":"150","author":"Nambou","year":"2022","journal-title":"Genetica"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e16448","DOI":"10.1002\/advs.202516448","article-title":"Genome-Wide Codon Reprogramming Enables a Multifactorially Attenuated Influenza Vaccine with Broad Cross-Protection","volume":"13","author":"Wang","year":"2026","journal-title":"Adv. Sci."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.vaccine.2015.11.054","article-title":"Evaluation of the attenuation, immunogenicity, and efficacy of a live virus vaccine generated by codon-pair bias de-optimization of the 2009 pandemic H1N1 influenza virus, in ferrets","volume":"34","author":"Broadbent","year":"2016","journal-title":"Vaccine"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"10762","DOI":"10.1128\/JVI.01443-15","article-title":"Generation of Live Attenuated Influenza Virus by Using Codon Usage Bias","volume":"89","author":"Fan","year":"2015","journal-title":"J. Virol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.vaccine.2018.01.027","article-title":"Vaccination of pigs with a codon-pair bias de-optimized live attenuated influenza vaccine protects from homologous challenge","volume":"36","author":"Kaplan","year":"2018","journal-title":"Vaccine"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nbt.1636","article-title":"Live attenuated influenza virus vaccines by computer-aided rational design","volume":"28","author":"Mueller","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"9481","DOI":"10.1073\/pnas.1307473110","article-title":"Deliberate reduction of hemagglutinin and neuraminidase expression of influenza virus leads to an ultraprotective live vaccine in mice","volume":"110","author":"Yang","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Dong, J., Dong, Z., Feng, P., Gao, Y., Li, J., Wang, Y., Han, L., Li, Z., Wang, Q., and Niu, X. (2023). Influenza Virus Carrying a Codon-Reprogrammed Neuraminidase Gene as a Strategy for Live Attenuated Vaccine. Vaccines, 11.","DOI":"10.3390\/vaccines11020391"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"vez038","DOI":"10.1093\/ve\/vez038","article-title":"Dinucleotide evolutionary dynamics in influenza A virus","volume":"5","author":"Gu","year":"2019","journal-title":"Virus Evol."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Le Nou\u00ebn, C., Collins, P.L., and Buchholz, U.J. (2019). Attenuation of Human Respiratory Viruses by Synonymous Genome Recoding. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.01250"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Sharp, C.P., Thompson, B.H., Nash, T.J., Diebold, O., Pinto, R.M., Thorley, L., Lin, Y.-T., Sives, S., Wise, H., and Clohisey Hendry, S. (2023). CpG dinucleotide enrichment in the influenza A virus genome as a live attenuated vaccine development strategy. PLoS Pathog., 19.","DOI":"10.1371\/journal.ppat.1011357"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nrg2290","article-title":"Mechanisms of post-transcriptional regulation by microRNAs: Are the answers in sight?","volume":"9","author":"Filipowicz","year":"2008","journal-title":"Nat. Rev. Genet."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Bayat, M., Nahid-Samiei, R., Sadri Nahand, J., and Naghili, B. (2025). Interferon and immunity: The role of microRNA in viral evasion strategies. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1567459"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"102149","DOI":"10.1016\/j.omtn.2024.102149","article-title":"Therapeutic role of miR-19a\/b protection from influenza virus infection in patients with coronary heart disease","volume":"35","author":"Xing","year":"2024","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Fay, E.J., and Langlois, R.A. (2018). MicroRNA-Attenuated Virus Vaccines. Non-Coding RNA, 4.","DOI":"10.3390\/ncrna4040025"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/nbt.1542","article-title":"MicroRNA-mediated species-specific attenuation of influenza A virus","volume":"27","author":"Perez","year":"2009","journal-title":"Nat. Biotechnol."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Gao, F., Yang, T., Liu, X., Xiong, F., Luo, J., Yi, Y., Fan, J., Chen, Z., and Tan, W.-S. (2020). MiRNA Targeted NP Genome of Live Attenuated Influenza Vaccines Provide Cross-Protection against a Lethal Influenza Virus Infection. Vaccines, 8.","DOI":"10.3390\/vaccines8010065"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"121325","DOI":"10.1016\/j.ijpharm.2021.121325","article-title":"A new self-attenuated therapeutic influenza vaccine that uses host cell-restricted attenuation by artificial microRNAs","volume":"612","author":"Wen","year":"2022","journal-title":"Int. J. Pharm."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1080\/15476286.2021.1907055","article-title":"Amber codon is genetically unstable in generation of premature termination codon (PTC)-harbouring Foot-and-mouth disease virus (FMDV) via genetic code expansion","volume":"18","author":"Hao","year":"2021","journal-title":"RNA Biol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1126\/science.aah5869","article-title":"Generation of influenza A viruses as live but replication-incompetent virus vaccines","volume":"354","author":"Si","year":"2016","journal-title":"Science"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s11427-020-1737-3","article-title":"Construction and characterization of UAA-controlled recombinant Zika virus by genetic code expansion","volume":"64","author":"Zhang","year":"2021","journal-title":"Sci. China Life Sci."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1126\/science.1060077","article-title":"Expanding the genetic code of Escherichia coli","volume":"292","author":"Wang","year":"2001","journal-title":"Science"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2157339","DOI":"10.1080\/22221751.2022.2157339","article-title":"A novel viral vaccine platform based on engineered transfer RNA","volume":"12","author":"Wang","year":"2023","journal-title":"Emerg. Microbes Infect."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1038\/s41467-025-57596-x","article-title":"A cysteine-less and ultra-fast split intein rationally engineered from being aggregation-prone to highly efficient in protein trans-splicing","volume":"16","author":"Humberg","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"19196","DOI":"10.1021\/jacs.2c08985","article-title":"A Conserved Histidine Residue Drives Extein Dependence in an Enhanced Atypically Split Intein","volume":"144","author":"Sekar","year":"2022","journal-title":"J. Am. Chem. Soc."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"10505","DOI":"10.1073\/pnas.0402762101","article-title":"Directed evolution of ligand dependence: Small-molecule-activated protein splicing","volume":"101","author":"Buskirk","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.chembiol.2011.02.014","article-title":"Directed evolution of a small-molecule-triggered intein with improved splicing properties in mammalian cells","volume":"18","author":"Peck","year":"2011","journal-title":"Chem. Biol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1021\/acssynbio.3c00020","article-title":"Generation of a Live Attenuated Influenza A Vaccine Using Chemical-Triggered Intein","volume":"12","author":"Chen","year":"2023","journal-title":"ACS Synth. Biol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"e02017","DOI":"10.1002\/adhm.202502017","article-title":"Selective Activation of Conditionally Replicating Influenza A Virus in Pulmonary Tumors for Enhanced Oncolytic Efficacy and Systemic Safety","volume":"15","author":"Chen","year":"2026","journal-title":"Adv. Healthc. Mater."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"8554","DOI":"10.1073\/pnas.141230798","article-title":"Protacs: Chimeric molecules that target proteins to the Skp1-Cullin-F box complex for ubiquitination and degradation","volume":"98","author":"Sakamoto","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41573-021-00371-6","article-title":"PROTAC targeted protein degraders: The past is prologue","volume":"21","author":"Langley","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12943-021-01434-3","article-title":"Proteolysis-targeting chimeras (PROTACs) in cancer therapy","volume":"21","author":"Li","year":"2022","journal-title":"Mol. Cancer"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/s41587-022-01381-4","article-title":"Generation of a live attenuated influenza A vaccine by proteolysis targeting","volume":"40","author":"Si","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1038\/s41589-025-01956-7","article-title":"Author Correction: PROTAR Vaccine 2.0 generates influenza vaccines by degrading multiple viral proteins","volume":"21","author":"Zhang","year":"2025","journal-title":"Nat. Chem. Biol."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Prokopenko, P., Matyushenko, V., Rak, A., Stepanova, E., Chistyakova, A., Goshina, A., Kudryavtsev, I., Rudenko, L., and Isakova-Sivak, I. (2023). Truncation of NS1 Protein Enhances T Cell-Mediated Cross-Protection of a Live Attenuated Influenza Vaccine Virus Expressing Wild-Type Nucleoprotein. Vaccines, 11.","DOI":"10.3390\/vaccines11030501"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"3722","DOI":"10.1016\/j.vaccine.2019.05.013","article-title":"Safety and immunogenicity of a replication-deficient H5N1 influenza virus vaccine lacking NS1","volume":"37","author":"Nicolodi","year":"2019","journal-title":"Vaccine"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1038\/s41467-025-58504-z","article-title":"Intranasal influenza virus-vectored vaccine offers protection against clade 2.3.4.4b H5N1 infection in small animal models","volume":"16","author":"Liu","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Chen, J., Wang, J., Zhang, J., and Ly, H. (2021). Advances in Development and Application of Influenza Vaccines. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.711997"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/j.scib.2022.05.018","article-title":"A live attenuated virus-based intranasal COVID-19 vaccine provides rapid, prolonged, and broad protection against SARS-CoV-2","volume":"67","author":"Chen","year":"2022","journal-title":"Sci. Bull."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"4117","DOI":"10.1038\/s41467-023-39560-9","article-title":"Intranasal influenza-vectored COVID-19 vaccine restrains the SARS-CoV-2 inflammatory response in hamsters","volume":"14","author":"Zhang","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S2213-2600(22)00131-X","article-title":"Safety and immunogenicity of a live-attenuated influenza virus vector-based intranasal SARS-CoV-2 vaccine in adults: Randomised, double-blind, placebo-controlled, phase 1 and 2 trials","volume":"10","author":"Zhu","year":"2022","journal-title":"Lancet Respir. Med."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S2213-2600(23)00349-1","article-title":"Safety and efficacy of the intranasal spray SARS-CoV-2 vaccine dNS1-RBD: A multicentre, randomised, double-blind, placebo-controlled, phase 3 trial","volume":"11","author":"Zhu","year":"2023","journal-title":"Lancet Respir. Med."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2235963","DOI":"10.1080\/21645515.2023.2235963","article-title":"Acceptability for the influenza virus vector COVID-19 vaccine for intranasal spray: A cross-sectional survey in Beijing, China","volume":"19","author":"Ma","year":"2023","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Jindra, C., Hainisch, E.K., R\u00fcmmele, A., Wolschek, M., Muster, T., and Brandt, S. (2021). Influenza virus vector iNS1 expressing bovine papillomavirus 1 (BPV1) antigens efficiently induces tumour regression in equine sarcoid patients. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0260155"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s40249-021-00801-y","article-title":"A new candidate vaccine for human brucellosis based on influenza viral vectors: A preliminary investigation for the development of an immunization schedule in a guinea pig model","volume":"10","author":"Bugybayeva","year":"2021","journal-title":"Infect. Dis. Poverty"},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Sergeeva, M., Romanovskaya-Romanko, E., Zabolotnyh, N., Pulkina, A., Vasilyev, K., Shurigina, A.P., Buzitskaya, J., Zabrodskaya, Y., Fadeev, A., and Vasin, A. (2021). Mucosal Influenza Vector Vaccine Carrying TB10.4 and HspX Antigens Provides Protection against Mycobacterium tuberculosis in Mice and Guinea Pigs. Vaccines, 9.","DOI":"10.3390\/vaccines9040394"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"e00059-21","DOI":"10.1128\/JVI.00059-21","article-title":"Mucosal Priming with a Recombinant Influenza A Virus-Vectored Vaccine Elicits T-Cell and Antibody Responses to HIV-1 in Mice","volume":"95","author":"Wang","year":"2021","journal-title":"J. Virol."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Beicht, J., Kubinski, M., Zdora, I., Puff, C., Biermann, J., Gerlach, T., Baumg\u00e4rtner, W., Sutter, G., Osterhaus, A.D.M.E., and Prajeeth, C.K. (2023). Induction of humoral and cell-mediated immunity to the NS1 protein of TBEV with recombinant Influenza virus and MVA affords partial protection against lethal TBEV infection in mice. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1177324"},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Pulkina, A., Vasilyev, K., Muzhikyan, A., Sergeeva, M., Romanovskaya-Romanko, E., Shurygina, A.-P., Shuklina, M., Vasin, A., Stukova, M., and Egorov, A. (2023). IgG\u03ba Signal Peptide Enhances the Efficacy of an Influenza Vector Vaccine against Respiratory Syncytial Virus Infection in Mice. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241411445"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"9647","DOI":"10.1038\/s41467-025-64651-0","article-title":"Live attenuated influenza vaccine with low proportions of defective interfering particles elicits robust immunogenicity and cross-protection","volume":"16","author":"Wu","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"e148763","DOI":"10.1172\/JCI148763","article-title":"Influenza vaccination in the elderly boosts antibodies against conserved viral proteins and egg-produced glycans","volume":"131","author":"Jung","year":"2021","journal-title":"J. Clin. Investig."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"3465","DOI":"10.1128\/jvi.69.6.3465-3474.1995","article-title":"Foot-and-mouth disease virus Lb proteinase can stimulate rhinovirus and enterovirus IRES-driven translation and cleave several proteins of cellular and viral origin","volume":"69","author":"Ziegler","year":"1995","journal-title":"J. Virol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0168-1702(99)00039-8","article-title":"Rhinovirus 2A proteinase mediated stimulation of rhinovirus RNA translation is additive to the stimulation effected by cellular RNA binding proteins","volume":"62","author":"Hunt","year":"1999","journal-title":"Virus Res."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"e02001-20","DOI":"10.1128\/JVI.02001-20","article-title":"Protein Tyrosine Phosphatase SHP2 Suppresses Host Innate Immunity against Influenza A Virus by Regulating EGFR-Mediated Signaling","volume":"95","author":"Wang","year":"2021","journal-title":"J. Virol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.omto.2017.09.002","article-title":"Targeting an Oncolytic Influenza A Virus to Tumor Tissue by Elastase","volume":"7","author":"Kuznetsova","year":"2017","journal-title":"Mol. Ther. Oncolytics"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1126\/science.aan8806","article-title":"Genome-wide identification of interferon-sensitive mutations enables influenza vaccine design","volume":"359","author":"Du","year":"2018","journal-title":"Science"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1158\/2326-6066.CIR-23-1075","article-title":"Hyper-Interferon Sensitive Influenza Induces Adaptive Immune Responses and Overcomes Resistance to Anti-PD-1 in Murine Non-Small Cell Lung Cancer","volume":"12","author":"Du","year":"2024","journal-title":"Cancer Immunol. Res."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/s41587-023-01796-7","article-title":"An engineered influenza virus to deliver antigens for lung cancer vaccination","volume":"42","author":"Ji","year":"2024","journal-title":"Nat. Biotechnol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"e76414","DOI":"10.7554\/eLife.76414","article-title":"Recombinant single-cycle influenza virus with exchangeable pseudotypes allows repeated immunization to augment anti-tumour immunity with immune checkpoint inhibitors","volume":"12","author":"Kandasamy","year":"2023","journal-title":"eLife"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"e004022","DOI":"10.1136\/jitc-2021-004022","article-title":"CD4+ T-cell epitope-based heterologous prime-boost vaccination potentiates anti-tumor immunity and PD-1\/PD-L1 immunotherapy","volume":"10","author":"Xiao","year":"2022","journal-title":"J. Immunother. Cancer"}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/18\/7\/715\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T06:04:44Z","timestamp":1782799484000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/18\/7\/715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":88,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["v18070715"],"URL":"https:\/\/doi.org\/10.3390\/v18070715","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,29]]}}}